Viewing Study NCT04539366


Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2026-03-01 @ 8:56 PM
Study NCT ID: NCT04539366
Status: SUSPENDED
Last Update Posted: 2025-11-03
First Post: 2020-09-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, The GD2-CAR PERSIST Trial
Sponsor:
Organization: